ResearcherInha UniversityNo recent work listed

Sun‐Mi Yun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4536-5762; OpenAlex author ID A5030816066. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2013: 1 paper

Papers 1

Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2013.01.007 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mi Kwon Son · 1 shared paper, 2013 · strength 0.04
- Paper Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic canc… DOI 10.1016/j.canlet.2013.01.007 ↗
Hong Hua Yan · 1 shared paper, 2013 · strength 0.04
- Paper Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic canc… DOI 10.1016/j.canlet.2013.01.007 ↗
Sungwoo Hong · 1 shared paper, 2013 · strength 0.04
- Paper Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic canc… DOI 10.1016/j.canlet.2013.01.007 ↗
Kyung Hee Jung · 1 shared paper, 2013 · strength 0.04
- Paper Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic canc… DOI 10.1016/j.canlet.2013.01.007 ↗
Soon‐Sun Hong · 1 shared paper, 2013 · strength 0.04
- Paper Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic canc… DOI 10.1016/j.canlet.2013.01.007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.